1
|
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
|
N Engl J Med
|
2004
|
10.51
|
2
|
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.
|
Nat Med
|
2003
|
8.95
|
3
|
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.
|
Nat Med
|
2002
|
7.59
|
4
|
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control.
|
J Clin Invest
|
2005
|
3.08
|
5
|
The emerging biology of the nitrite anion.
|
Nat Chem Biol
|
2005
|
2.88
|
6
|
Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation.
|
Blood
|
2005
|
2.76
|
7
|
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.
|
J Clin Invest
|
2005
|
2.75
|
8
|
Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation.
|
Circulation
|
2007
|
2.46
|
9
|
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
|
Blood
|
2007
|
2.30
|
10
|
NO contest: nitrite versus S-nitroso-hemoglobin.
|
Circ Res
|
2004
|
2.21
|
11
|
Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator.
|
Nat Med
|
2004
|
2.09
|
12
|
Erythrocytes are the major intravascular storage sites of nitrite in human blood.
|
Blood
|
2005
|
2.08
|
13
|
Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.
|
J Clin Invest
|
2003
|
2.00
|
14
|
Divergent nitric oxide bioavailability in men and women with sickle cell disease.
|
Circulation
|
2003
|
1.98
|
15
|
Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols.
|
Crit Care Med
|
2007
|
1.88
|
16
|
Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans.
|
Free Radic Biol Med
|
2005
|
1.85
|
17
|
Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.79
|
18
|
Red blood cell magnetophoresis.
|
Biophys J
|
2003
|
1.78
|
19
|
S-Nitrosohemoglobin is unstable in the reductive erythrocyte environment and lacks O2/NO-linked allosteric function.
|
J Biol Chem
|
2002
|
1.62
|
20
|
Nitric oxide's reactions with hemoglobin: a view through the SNO-storm.
|
Nat Med
|
2003
|
1.61
|
21
|
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.
|
Br J Haematol
|
2002
|
1.52
|
22
|
Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.
|
Blood
|
2004
|
1.43
|
23
|
The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions.
|
Free Radic Biol Med
|
2006
|
1.38
|
24
|
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells.
|
Blood
|
2007
|
1.27
|
25
|
Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation.
|
PLoS One
|
2012
|
1.23
|
26
|
Exogenous reference RNA for normalization of real-time quantitative PCR.
|
Biotechniques
|
2003
|
1.19
|
27
|
The reaction between nitrite and oxyhemoglobin: a mechanistic study.
|
J Biol Chem
|
2008
|
1.14
|
28
|
Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration.
|
Transfusion
|
2004
|
1.12
|
29
|
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells.
|
Blood
|
2006
|
1.12
|
30
|
Emerging role of nitrite in human biology.
|
Blood Cells Mol Dis
|
2004
|
1.07
|
31
|
Funding priorities for medical research.
|
JAMA
|
2002
|
1.06
|
32
|
Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes.
|
Nitric Oxide
|
2007
|
1.03
|
33
|
Fetal hemoglobin silencing in humans.
|
Blood
|
2006
|
1.03
|
34
|
Translational medicine--doing it backwards.
|
J Transl Med
|
2010
|
1.03
|
35
|
Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits.
|
Eur J Nutr
|
2011
|
1.03
|
36
|
Effect of blood nitrite and nitrate levels on murine platelet function.
|
PLoS One
|
2013
|
1.00
|
37
|
NIH support for basic and clinical research: biomedical researcher angst in 2006.
|
JAMA
|
2006
|
0.99
|
38
|
Effects of iron nitrosylation on sickle cell hemoglobin solubility.
|
J Biol Chem
|
2002
|
0.98
|
39
|
Inorganic nitrate: a major player in the cardiovascular health benefits of vegetables?
|
Nutr Rev
|
2012
|
0.98
|
40
|
Electron paramagnetic resonance analysis of nitrosylhemoglobin in humans during NO inhalation.
|
J Biol Chem
|
2005
|
0.94
|
41
|
Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells.
|
Cytokine
|
2011
|
0.89
|
42
|
Increased reticulocytosis during infancy is associated with increased hospitalizations in sickle cell anemia patients during the first three years of life.
|
PLoS One
|
2013
|
0.88
|
43
|
Acute erythropoietin cardioprotection is mediated by endothelial response.
|
Basic Res Cardiol
|
2011
|
0.88
|
44
|
Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration.
|
Transfusion
|
2002
|
0.88
|
45
|
Oxidation of iron-nitrosyl-hemoglobin by dehydroascorbic acid releases nitric oxide to form nitrite in human erythrocytes.
|
Biochemistry
|
2008
|
0.86
|
46
|
Measurement of nitrite in blood samples using the ferricyanide-based hemoglobin oxidation assay.
|
Methods Mol Biol
|
2011
|
0.84
|
47
|
Increasing oxygen tension improves filtration of sickle trait donor blood.
|
Br J Haematol
|
2003
|
0.83
|
48
|
The reaction of cell-free oxyhemoglobin with nitrite under physiologically relevant conditions: Implications for nitrite-based therapies.
|
Nitric Oxide
|
2008
|
0.83
|
49
|
Hydroxyurea increases eNOS protein levels through inhibition of proteasome activity.
|
Nitric Oxide
|
2007
|
0.82
|
50
|
Effects of nitric oxide on red blood cell development and phenotype.
|
Curr Top Dev Biol
|
2008
|
0.82
|
51
|
Globin gene expression in correlation with G protein-related genes during erythroid differentiation.
|
BMC Genomics
|
2013
|
0.80
|
52
|
The role of nitrite in neurovascular coupling.
|
Brain Res
|
2011
|
0.80
|
53
|
Comments on 'vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway'.
|
Br J Clin Pharmacol
|
2013
|
0.80
|
54
|
JAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny.
|
J Transl Med
|
2012
|
0.79
|
55
|
Identification and characterization of mechanistically distinct inducers of gamma-globin transcription.
|
Biochem Pharmacol
|
2003
|
0.78
|
56
|
Effect of storage on levels of nitric oxide metabolites in platelet preparations.
|
Transfusion
|
2012
|
0.77
|
57
|
Correction: Nitrate Reduction to Nitrite, Nitric Oxide and Ammonia by Gut Bacteria under Physiological Conditions.
|
PLoS One
|
2015
|
0.76
|
58
|
How do red blood cells dilate blood vessels?--Reply.
|
Circ Res
|
2004
|
0.75
|
59
|
Stimulated stromal cells induce gamma-globin gene expression in erythroid cells via nitric oxide production.
|
Exp Hematol
|
2009
|
0.75
|
60
|
To publish or not to publish?
|
J Lab Clin Med
|
2005
|
0.75
|
61
|
Introduction to the symposium on synthetic life.
|
Perspect Biol Med
|
2012
|
0.75
|
62
|
In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines.
|
Transfusion
|
2013
|
0.75
|
63
|
In reply.
|
Transfusion
|
2013
|
0.75
|
64
|
Linderstrom-Lang-Schellman's model for protein stabilization revisited.
|
Curr Protein Pept Sci
|
2004
|
0.75
|
65
|
Introduction to the symposium on recurrent debates on the causal role of genes.
|
Perspect Biol Med
|
2014
|
0.75
|
66
|
General Introduction.
|
Perspect Biol Med
|
2015
|
0.75
|